s-2-4-2-2-amino-4-oxo-47-dihydro-1h-pyrrolo23-dpyrimidin-5-ylethylbenzamidopentanedioic-acid-sodium-salt-25-hydrate

357166-30-4 (S)-2-(4-(2-(2-Amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)pentanedioic acid, sodium salt 2.5 hydrate

Synonym(s):

Pemetrexed Disodium Hemipentahydrate; Ciambra; Disodium (2S)-2-[[4-[2-(2-Amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioate 2.5-Hydrate;Pemitrexide disodium 2.5 Hydrate

Purity : > 99 %

CAS Number: 357166-30-4

Molecular Weight:

Emperical Formula

EC Number:

MDL Number:

SKU	Pack Size	Availability	Price	Quantity
Pemetrexed disodium 2.5-hydrate	1 / Grams	Available to ship on 31-10-2024 (Three weeks from Order Confirmation)	₹ 42,500	- +

Request a Bulk Order

Product Number

CLSOP1004

Purity / Analysis Method

> > 99 %

Molecular Formula / Molecular Weight

Physical State (20 deg.C)

Solid

Packaging and Container

CAS RN

Reaxys Registry Number

PubChem Substance ID

SDBS (AIST Spectral DB)

Merck Index (14)

MDL Number

Specifications

Appearance

Purity(HPLC)

Purity(Neutralization titration)

Properties (reference)

Melting Point

Solubility in water

Solubility (soluble in)

GHS

Signal Word

Hazard Statements

Precautionary Statements

Related Laws:

RTECS#

Transport Information:

Pemetrexed disodium hemipenta hydrate is a drug that is used in the treatment of cancer. It is an inhibitor of the enzyme dihydrofolate reductase, which prevents the synthesis of DNA and RNA. Pemetrexed disodium hemipenta hydrate is not toxic to normal cells and has minimal side effects. This drug has been shown to inhibit tumor growth in mouse models and human patients with lung cancer. Pemetrexed disodium hemipenta hydrate is administered intravenously as an injection solution for cancer treatment trials.